[Guideline 'Treatment of breast cancer 2008' (revision)].
The Dutch evidence-based guideline 'Treatment of breast cancer' has been revised, and integrated with the guideline 'Screening for and diagnosis of breast cancer'. The guideline can be found on www. oncoline.nl and on www.cbo.nl. The Internet programme 'Adjuvant!' (www.adjuvantonline.com) can be used to predict both the prognosis and the efficacy of systemic adjuvant therapy for each patient. The indications for adjuvant chemotherapy and endocrine therapy have been widened. The aim is to reduce the absolute probability of death by at least 4-5% within 10 years. The goal of neoadjuvant chemotherapy in operable breast cancer is to enable breast-conserving therapy for large tumours in relatively small breasts. One could consider transferring responsibility for follow-up after 5 years from the hospital to the screening organisation following mastectomy, to the family doctor following breast-conserving therapy, and to an outpatient clinic for hereditary tumours in carriers of gene mutation. Cessation of follow-up above the age of 75 could also be considered.
Struikmans
H
H
Medisch Centrum Haaglanden, afd. Radiotherapie, Den Haag. h.struikmans@mchaaglanden.nl
Nortier
J W R
JW
Rutgers
E J Th
EJ
Zonderland
H M
HM
Bontenbal
M
M
Elkhuizen
P H M
PH
van Tienhoven
G
G
Tjan-Heijnen
V C G
VC
van Vegchel
T
T
Tuut
M K
MK
Benraadt
J
J
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000401:mortality / Q000601:surgery / Q000628:therapy*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008408:Mastectomy; D020360:Neoadjuvant Therapy / Q000379:methods*; D009367:Neoplasm Staging; D009426:Netherlands; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians'; D011379:Prognosis; D012955:Societies, Medical; D016896:Treatment Outcome